HSBC analyst Karen Choi initiates coverage on Samsung Biologics (207940:KS) with a Buy rating and a price target of KRW2,100,000.00.The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE